Skip to main content

Want a detailed portfolio tracker?

Mineralys Therapeutics (MLYS) P/E (2023 - 2026)

Mineralys Therapeutics (MLYS) P/E from Mar 31, 2023 to Jul 21, 2026. The TTM Mineralys Therapeutics (MLYS) P/E is -14.87. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mineralys Therapeutics (MLYS)

YearP/EChange
2026-14.87-17.58%
2025-18.04+385.20%
2024-3.72-53.57%
2023-8.01N/A

Comparison Mineralys Therapeutics (MLYS) P/E with competitors

Mineralys Therapeutics (MLYS) P/E is -14.87.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.50%
FGENFibroGen Inc0.24-101.61%
CHRSCoherus Biosciences Inc0.85-105.71%
FBIOFortress Biotech Inc0.95-106.38%
ORMPOramed Pharmaceuticals Inc1.50-110.11%
AGENAgenus Inc3.01-120.24%
INVAInnoviva Inc3.15-121.21%
VXRTVaxart Inc3.55-123.87%
CRMDCorMedix Inc3.63-124.40%
CVACCureVac N.V.4.45-129.89%
GLPGGalapagos NV4.86-132.67%
SRPTSarepta Therapeutics Inc4.88-132.83%
ABEOAbeona Therapeutics Inc5.39-136.23%
ABUSArbutus Biopharma Corp5.60-137.62%
ZVRAZevra Therapeutics Inc5.89-139.59%
SPROSpero Therapeutics Inc6.23-141.88%
CGENCompugen Ltd6.31-142.45%
RIGLRigel Pharmaceuticals6.87-146.21%
SLXNSilexion Therapeutics Corp7.30-149.06%
OMEROmeros Corporation9.26-162.26%
AUPHAurinia Pharmaceuticals Inc9.58-164.45%
PLXProtalix BioTherapeutics Inc10.89-173.23%
ACADAcadia Pharmaceuticals Inc11.73-178.86%
TBPHTheravance Biopharma Inc12.26-182.45%
ADMAAdma Biologics Inc12.42-183.50%
HRMYHarmony Biosciences Holdings Inc13.82-192.93%
SABSSAB Biotherapeutics Inc14.14-195.05%
NAGENiagen Bioscience Inc14.82-199.64%
INCYIncyte Corp15.82-206.39%
REGNRegeneron Pharmaceuticals Inc15.86-206.62%
PBYIPuma Biotechnology Inc17.32-216.43%
CPRXCatalyst Pharmaceuticals Inc17.44-217.26%
EXELExelixis Inc17.54-217.93%
TGTXTG Therapeutics Inc18.97-227.53%
MDXGMimedx Group Inc20.55-238.19%
XOMAXOMA Royalty Corp22.87-253.81%
ARGXArgen X SE24.30-263.38%
CTMXCytomX Therapeutics Inc24.82-266.90%
XOMAOXOMA Royalty Corp25.34-270.42%
HALOHalozyme Therapeutics Inc25.62-272.30%
XOMAPXOMA Royalty Corp25.67-272.61%
VRTXVertex Pharmaceuticals Inc27.99-288.24%
RPRXRoyalty Pharma plc - Class A28.69-292.90%
SLNOSoleno Therapeutics Inc29.02-295.10%
ASNDAscendis Pharma A/S30.09-302.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-354.93%
APLSApellis Pharmaceuticals Inc39.02-362.39%
BMRNBiomarin Pharmaceutical Inc42.21-383.84%
KRYSKrystal Biotech Inc45.34-404.90%
ONCBeiGene Ltd69.54-567.60%
PHARPharming Group N.V.75.03-604.48%
TECHBio-Techne Corp101.96-785.59%
VCELVericel Corp109.92-839.13%
ALNYAlnylam Pharmaceuticals Inc117.96-893.22%
GMABGenmab140.29-1043.34%
TLXTelix Pharmaceuticals Ltd162.15-1190.34%
CORTCorcept Therapeutics Inc212.86-1531.29%